Fig. 3From: Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in GermanyResults of sensitivity analyses. *Re-test scenario A: Re-test applied to 6.5% of women with initial ratio ≤ 38 who did not develop preeclampsia at week two and who were treated in an outpatient setting. **Re-test scenario B: Re-test applied to all women irrespective of the initial test result, preeclampsia status at week two and treatment locationBack to article page